← Back to Clinical Trials
Recruiting NCT06815939

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Trial Parameters

Condition Human Papillomavirus (HPV)
Sponsor DL Analytics
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10,000
Sex FEMALE
Min Age 30 Years
Max Age 59 Years
Start Date 2025-02-12
Completion 2026-07-31
Interventions
HPV TestEVA SystemVisual Inspection with Acetic Acid (VIA)

Brief Summary

The purpose of this study is to validate Automated Visual Evaluation (AVE), specifically the CINFinder version developed by DL Analytics, a point-of-care screening and triage diagnostic tool for cervical cancer based on the assessment of digital images through artificial intelligence. Several teams around the world have developed versions of AVE as a triage technology but none as a screening tool.

Eligibility Criteria

Inclusion Criteria: * Women between 30 and 59 years of age Exclusion Criteria: * Pregnancy at the time of colposcopy/biopsy * Hysterectomy with surgically absent cervix * HPV test in the last 5 years independently of negative or positive result * Previous cervical cancer diagnosis or treatment in the last 5 years * Lack of willingness or capacity to provide informed consent

Related Trials